BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14612152)

  • 1. What can be learned from studies of multisubstrate mechanisms of neuronal dopamine transport?
    Schenk JO; George SE; Schumacher PD
    Eur J Pharmacol; 2003 Oct; 479(1-3):223-8. PubMed ID: 14612152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate.
    Schenk JO
    Prog Drug Res; 2002; 59():111-31. PubMed ID: 12458965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine.
    Povlock SL; Schenk JO
    J Neurochem; 1997 Sep; 69(3):1093-105. PubMed ID: 9282932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter.
    Bonnet JJ
    Eur J Pharmacol; 2003 Oct; 479(1-3):199-212. PubMed ID: 14612150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
    Kahlig KM; Galli A
    Eur J Pharmacol; 2003 Oct; 479(1-3):153-8. PubMed ID: 14612146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling neuronal dopamine transporter mechanisms with rotating disk electrode voltammetry.
    Schenk JO; Wright C; Bjorklund N
    J Neurosci Methods; 2005 Apr; 143(1):41-7. PubMed ID: 15763135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and regulation of the neuronal dopamine transporter.
    Reith ME; Xu C; Chen NH
    Eur J Pharmacol; 1997 Apr; 324(1):1-10. PubMed ID: 9137907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
    Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
    J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
    Volz TJ; Schenk JO
    Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic regulation of the dopamine transporter.
    Mortensen OV; Amara SG
    Eur J Pharmacol; 2003 Oct; 479(1-3):159-70. PubMed ID: 14612147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
    Chen N; Zhen J; Reith ME
    J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine efflux via wild-type and mutant dopamine transporters: alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations.
    Itokawa M; Lin Z; Uhl GR
    Brain Res Mol Brain Res; 2002 Dec; 108(1-2):71-80. PubMed ID: 12480180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
    Volz TJ; Kim M; Schenk JO
    Synapse; 2004 Jun; 52(4):272-82. PubMed ID: 15103693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration.
    Storch A; Ludolph AC; Schwarz J
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1267-86. PubMed ID: 15480838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential.
    Chen N; Reith ME
    J Neurochem; 2004 May; 89(3):750-65. PubMed ID: 15086531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine self-administration in dopamine-transporter knockout mice.
    Rocha BA; Fumagalli F; Gainetdinov RR; Jones SR; Ator R; Giros B; Miller GW; Caron MG
    Nat Neurosci; 1998 Jun; 1(2):132-7. PubMed ID: 10195128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporters depolarize neurons by a channel mechanism.
    Carvelli L; McDonald PW; Blakely RD; DeFelice LJ
    Proc Natl Acad Sci U S A; 2004 Nov; 101(45):16046-51. PubMed ID: 15520385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.